Medicare appeal denials surge leaving seniors fighting insurers for lifesaving treatments
Background
Medicare beneficiaries and their clinicians say they are increasingly pushed into an uphill battle to secure routine and critical care after insurers deny coverage and leave families scrambling to file appeals. New federal and independent analyses show a dramatic rise in prior authorization activity in Medicare Advantage plans, with nearly 53 million prior authorization determinations made in 2024 and about 4.1 million of those fully or partially denied. That equates to roughly 7.7 percent of requests, a notable jump from prior years. When beneficiaries do appeal, the majority of decisions are reversed, but only a small share of denials are ever challenged.
Patient consequences
The practical cost of those denials has been stark. Doctors and families report delays in getting chemotherapy infusions, home health services, behavioral health care and post-acute rehabilitation covered, in some cases forcing patients to defer or forgo treatment. Reporting documented cases in which repeated insurer denials left a patient without timely inpatient behavioral health care despite clinicians' recommendations. These fights can mean days or weeks before care is authorized, and bills that land on patients if appeals take months.
Why appeals fall short
Experts point to several systemic problems. Insurers have expanded automated triage and prior authorization programs, driving volume and complexity. Clinicians say administrative burdens and staffing shortages make it difficult for providers to mount appeals, and many patients assume a denial is final. Data show a substantial proportion of denials that are appealed are overturned, yet only about 11.5 percent of denied requests are formally appealed in Medicare Advantage plans, a gap that magnifies harm because overturned denials reveal frequent errors in insurer decisions. Professional groups also report rising denial rates compared with earlier in the decade.
Policy and oversight
Lawmakers and regulators have tried, and repeatedly stalled, to tighten rules around prior authorization and to increase transparency. Recent congressional attention produced hearings that highlighted bipartisan frustration with insurers, but legislation aimed at limiting denials and streamlining appeals has yet to pass. Meanwhile, implementation of new federal requirements that force plans to publish denial and appeal statistics has increased public scrutiny, but critics say enforcement and timelines remain uneven. At the same time, some experimental payment or care models in traditional Medicare have coincided with spikes in administrative denials in pilot regions, drawing fresh complaints from patient advocates and members of Congress.
What comes next
Clinicians and consumer advocates are calling for simpler appeal pathways, faster independent medical reviews, and clearer accountability for plans with high denial and low overturn rates. Until changes arrive, families face a system where administrative obstacles can determine access to treatment as much as medical need. The data point to a pattern: increased denials, low appeal rates, and frequent reversals when cases are pursued. That combination leaves seniors bearing both health risk and financial exposure while waiting for reforms that may take months or years to implement.